Narayana Hrudayalaya Share Price
Sector: Healthcare Facilities
2038.30 -32.50 (-1.57%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2030
Today’s High
2088.35
52 Week Low
1171.35
52 Week High
2145
2050.60 -22.70 (-1.09%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2046
Today’s High
2087.50
52 Week Low
1171
52 Week High
2145.90
Key Metrics
- Market Cap (In Cr) 41658.46
- Beta 0.59
- Div. Yield (%) 0.22
- P/B 11.61
- TTM P/E 43.54
- Peg Ratio 1.66
- Sector P/E 22.44
- D/E 0.01
- Open Price 2088.35
- Prev Close 2070.8
Narayana Hrudayalaya Analysis
Price Analysis
-
1 Week10.65%
-
3 Months23.9%
-
6 Month58.12%
-
YTD62.89%
-
1 Year73.35%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 2
- Buy
- 4
- 4
- 5
- 5
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 3
- 3
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 9
- 9
- 8
- 8
Narayana Hrudayalaya News
This stock defied the market correction. Here’s why it could keep rising
4 min read . 26 Mar 2025Betting on the future: Five high-growth stocks poised for long-term success
7 min read . 07 Mar 2025Stock picks for today as recommended by India’s top market experts
2 min read . 06 Mar 2025Narayana Hrudayalaya Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 5482.98
- Selling/ General/ Admin Expenses Total
- 1092.72
- Depreciation/ Amortization
- 278.11
- Other Operating Expenses Total
- 1045.09
- Total Operating Expense
- 4493.07
- Operating Income
- 989.91
- Net Income Before Taxes
- 935.54
- Net Income
- 790.16
- Diluted Normalized EPS
- 39.21
- Period
- 2025
- Total Assets
- 7265.03
- Total Liabilities
- 3638.67
- Total Equity
- 3626.36
- Tangible Book Valueper Share Common Eq
- 166.58
- Period
- 2025
- Cashfrom Operating Activities
- 985.78
- Cashfrom Investing Activities
- -1325.32
- Cashfrom Financing Activities
- 544.31
- Net Changein Cash
- 205.42
- Period
- 2024
- Total Revenue
- 5018.25
- Selling/ General/ Admin Expenses Total
- 1381.31
- Depreciation/ Amortization
- 242.14
- Other Operating Expenses Total
- 4.79
- Total Operating Expense
- 4101.77
- Operating Income
- 916.48
- Net Income Before Taxes
- 888.53
- Net Income
- 789.26
- Diluted Normalized EPS
- 39.08
- Period
- 2024
- Total Assets
- 5624.58
- Total Liabilities
- 2740.9
- Total Equity
- 2883.68
- Tangible Book Valueper Share Common Eq
- 129.63
- Period
- 2024
- Cashfrom Operating Activities
- 1066.6
- Cashfrom Investing Activities
- -1457.94
- Cashfrom Financing Activities
- 488.45
- Net Changein Cash
- 97.15
- Period
- 2023
- Total Revenue
- 4524.77
- Selling/ General/ Admin Expenses Total
- 1259.72
- Depreciation/ Amortization
- 210.04
- Other Operating Expenses Total
- 4.28
- Total Operating Expense
- 3746.5
- Operating Income
- 778.27
- Net Income Before Taxes
- 751.58
- Net Income
- 606.25
- Diluted Normalized EPS
- 29.48
- Period
- 2023
- Total Assets
- 4162.09
- Total Liabilities
- 2030.71
- Total Equity
- 2131.38
- Tangible Book Valueper Share Common Eq
- 90.44
- Period
- 2023
- Cashfrom Operating Activities
- 1084.56
- Cashfrom Investing Activities
- -1174.1
- Cashfrom Financing Activities
- 87.74
- Net Changein Cash
- -3.93
- Period
- 2022
- Total Revenue
- 3701.32
- Selling/ General/ Admin Expenses Total
- 1045.24
- Depreciation/ Amortization
- 183.48
- Other Operating Expenses Total
- 2.03
- Total Operating Expense
- 3220.1
- Operating Income
- 481.22
- Net Income Before Taxes
- 429.78
- Net Income
- 341.93
- Diluted Normalized EPS
- 16.96
- Period
- 2022
- Total Assets
- 3130.53
- Total Liabilities
- 1641.9
- Total Equity
- 1488.64
- Tangible Book Valueper Share Common Eq
- 67.53
- Period
- 2022
- Cashfrom Operating Activities
- 485.02
- Cashfrom Investing Activities
- -266.91
- Cashfrom Financing Activities
- -158.95
- Net Changein Cash
- 59.02
- Period
- 2021
- Total Revenue
- 2582.35
- Selling/ General/ Admin Expenses Total
- 851.74
- Depreciation/ Amortization
- 183.53
- Other Operating Expenses Total
- 1.66
- Total Operating Expense
- 2577.06
- Operating Income
- 5.29
- Net Income Before Taxes
- -56.07
- Net Income
- -14.3
- Diluted Normalized EPS
- -0.54
- Period
- 2021
- Total Assets
- 2770.02
- Total Liabilities
- 1649.74
- Total Equity
- 1120.28
- Tangible Book Valueper Share Common Eq
- 49.02
- Period
- 2021
- Cashfrom Operating Activities
- 309.05
- Cashfrom Investing Activities
- -112.99
- Cashfrom Financing Activities
- -198.43
- Net Changein Cash
- -2.34
- Period
- 2020
- Total Revenue
- 3127.81
- Selling/ General/ Admin Expenses Total
- 968.56
- Depreciation/ Amortization
- 185.8
- Other Operating Expenses Total
- 1.39
- Total Operating Expense
- 2900.02
- Operating Income
- 227.79
- Net Income Before Taxes
- 161.31
- Net Income
- 118.92
- Diluted Normalized EPS
- 6.5
- Period
- 2020
- Total Assets
- 2891.06
- Total Liabilities
- 1755.1
- Total Equity
- 1135.96
- Tangible Book Valueper Share Common Eq
- 49.23
- Period
- 2020
- Cashfrom Operating Activities
- 443.34
- Cashfrom Investing Activities
- -188.54
- Cashfrom Financing Activities
- -246.95
- Net Changein Cash
- 7.49
- Period
- 2019
- Total Revenue
- 2860.92
- Selling/ General/ Admin Expenses Total
- 947.39
- Depreciation/ Amortization
- 137.36
- Other Operating Expenses Total
- 6.03
- Total Operating Expense
- 2712.27
- Operating Income
- 148.65
- Net Income Before Taxes
- 93.4
- Net Income
- 59.17
- Diluted Normalized EPS
- 2.95
- Period
- 2019
- Total Assets
- 2637.05
- Total Liabilities
- 1555.91
- Total Equity
- 1081.14
- Tangible Book Valueper Share Common Eq
- 45.77
- Period
- 2019
- Cashfrom Operating Activities
- 278.65
- Cashfrom Investing Activities
- -161.29
- Cashfrom Financing Activities
- -27.29
- Net Changein Cash
- 89.35
- Period
- 2025-03-31
- Total Revenue
- 1475.44
- Selling/ General/ Admin Expenses Total
- 275.39
- Depreciation/ Amortization
- 82.5
- Other Operating Expenses Total
- 300.34
- Total Operating Expense
- 1208.58
- Operating Income
- 266.86
- Net Income Before Taxes
- 253.02
- Net Income
- 197.21
- Diluted Normalized EPS
- 9.98
- Period
- 2025-03-31
- Total Assets
- 7265.03
- Total Liabilities
- 3638.67
- Total Equity
- 3626.36
- Tangible Book Valueper Share Common Eq
- 166.58
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 985.78
- Cashfrom Investing Activities
- -1325.32
- Cashfrom Financing Activities
- 544.31
- Net Changein Cash
- 205.42
- Period
- 2024-12-31
- Total Revenue
- 1366.68
- Selling/ General/ Admin Expenses Total
- 277.27
- Depreciation/ Amortization
- 69.97
- Other Operating Expenses Total
- 269.47
- Total Operating Expense
- 1129.64
- Operating Income
- 237.04
- Net Income Before Taxes
- 218.82
- Net Income
- 192.94
- Diluted Normalized EPS
- 9.5
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1400
- Selling/ General/ Admin Expenses Total
- 282.05
- Depreciation/ Amortization
- 65.13
- Other Operating Expenses Total
- 263.99
- Total Operating Expense
- 1156.71
- Operating Income
- 243.3
- Net Income Before Taxes
- 231.77
- Net Income
- 198.63
- Diluted Normalized EPS
- 9.78
- Period
- 2024-09-30
- Total Assets
- 6242.86
- Total Liabilities
- 3037.21
- Total Equity
- 3205.65
- Tangible Book Valueper Share Common Eq
- 145.68
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 599.93
- Cashfrom Investing Activities
- -536.28
- Cashfrom Financing Activities
- -59.76
- Net Changein Cash
- 3.93
- Period
- 2024-06-30
- Total Revenue
- 1340.95
- Selling/ General/ Admin Expenses Total
- 276.36
- Depreciation/ Amortization
- 61.65
- Other Operating Expenses Total
- 236.69
- Total Operating Expense
- 1098.74
- Operating Income
- 242.21
- Net Income Before Taxes
- 231.69
- Net Income
- 201.38
- Diluted Normalized EPS
- 9.92
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1275.94
- Selling/ General/ Admin Expenses Total
- 249.37
- Depreciation/ Amortization
- 64.79
- Other Operating Expenses Total
- 224.18
- Total Operating Expense
- 1046.1
- Operating Income
- 229.84
- Net Income Before Taxes
- 225.62
- Net Income
- 190.69
- Diluted Normalized EPS
- 9.39
- Period
- 2024-03-31
- Total Assets
- 5624.58
- Total Liabilities
- 2740.9
- Total Equity
- 2883.68
- Tangible Book Valueper Share Common Eq
- 129.63
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1066.6
- Cashfrom Investing Activities
- -1457.94
- Cashfrom Financing Activities
- 488.45
- Net Changein Cash
- 97.15
- Period
- 2023-12-31
- Total Revenue
- 1203.64
- Selling/ General/ Admin Expenses Total
- 254.24
- Depreciation/ Amortization
- 63.19
- Other Operating Expenses Total
- 207.76
- Total Operating Expense
- 987.88
- Operating Income
- 215.76
- Net Income Before Taxes
- 208.58
- Net Income
- 188.02
- Diluted Normalized EPS
- 9.26
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Narayana Hrudayalaya Technical
Moving Average
SMA
- 5 Day1930.93
- 10 Day1906.5
- 20 Day1832.02
- 50 Day1798.13
- 100 Day1651.85
- 300 Day1464.34
Narayana Hrudayalaya Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Apollo Hospitals Enterprise
- 7157.75
- 56.1
- 0.79
- 7545.1
- 6002.15
- 102816.69
- Fortis Healthcare
- 798.1
- 7.2
- 0.91
- 793.35
- 452.75
- 60380.99
- Narayana Hrudayalaya
- 2038.3
- -32.5
- -1.57
- 2145
- 1171.35
- 41692.21
- Global Health
- 1149.15
- 17.25
- 1.52
- 1323.85
- 936.05
- 30834.66
- Aster Dm Healthcare
- 588
- -8.6
- -1.44
- 609
- 315.5
- 30465.52
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Apollo Hospitals Enterprise
- 70.03
- 12.33
- 15
- 5.46
- Fortis Healthcare
- 69.55
- 6.6
- 6.88
- 9.18
- Narayana Hrudayalaya
- 52.51
- 11.53
- 25.11
- 11.8
- Global Health
- 58.41
- 8.94
- 14.18
- 11.38
- Aster Dm Healthcare
- 86.15
- 8.6
- 6.16
- 4.98
Narayana Hrudayalaya Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 23-May-25
- Audited Results, Final Dividend & Others
- 14-Feb-25
- Quarterly Results
- 31-Oct-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 24-May-24
- Audited Results & Final Dividend
- 14-Feb-24
- Quarterly Results
- 13-Nov-23
- Quarterly Results
- 02-Aug-23
- Quarterly Results
- 19-May-23
- Audited Results & Final Dividend
- 08-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 29-Aug-25
- 23-May-25
- AGM
- 13-Jan-25
- 11-Dec-24
- POM
- 30-Aug-24
- 12-Aug-24
- AGM
- 04-Aug-23
- 19-May-23
- AGM
- 03-May-23
- 03-Apr-23
- POM
- 30-Aug-22
- 20-May-22
- AGM
- 26-Mar-22
- 21-Feb-22
- POM
- 27-Aug-21
- 31-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 23-May-25
- 01-Aug-25
- -
- 4.5
- 24-May-24
- 02-Aug-24
- 02-Aug-24
- 4
- 19-May-23
- 07-Jul-23
- 07-Jul-23
- 2.5
- 20-May-22
- 23-Aug-22
- 22-Aug-22
- 1


